There's no scenario where hearing the word "cancer" isn't terrifying and all-consuming. My research at Fred Hutch focuses on strategies to lower side effects and increase patients’ time at home during treatment for myeloma.
"Precision oncology" based on the genetics of individual cancer cells is still a work in progress, but "precision health care delivery" isn't. For me, this means taking into account side effects, the impact of those side effects on quality of life (both for patients and their loved ones), financial and logistical considerations and many other things. My clinical care and research both focus on improving these parts of the patient experience.
I am a hematologist-oncologist who sees patients at Fred Hutch and UW Medical Center – Montlake.
The "good" news about myeloma, if it can be called that, is that most patients can expect to live several years with their diagnosis. But myeloma still holds too big of a part of patients' lives, even if their cancer is in remission – for example, medication side effects, impaired immunity and expensive co-pays. Working to improve the patient experience during multiple myeloma is an exciting and important area of research that I'm very passionate about.
Warren Alpert Medical School, Brown University
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.